CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...

This turns them into CAR T cells. Before you get your CAR T cells back, you will get chemotherapy to prepare your body for treatment. When your CAR T cells come from the lab, we put them back in your ...

This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.

New CAR-T cell therapy shows promise for hard-to-treat cancers Date: March 10, 2025 Source: University of Colorado Anschutz Medical Campus Summary: Researchers have successfully developed a ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large B-cell lymphoma.

CAR-T cell therapy is an individualised treatment ... intravenous infusion following the administration of a round of chemotherapy designed to accommodate the new cells and minimise the patient ...